tert-Butyl (1R,3S,5S)-8-azabicyclo[3.2.1]octan-3-ylcarbamate, 95.0%, 10g

Ethyl 1-methylimidazo[1,5-a]pyridine-3-carboxylate, 95.0%, 100mg

Tetrahydrofuran D8, 99.5 at%D, 10 ml, glass packaging

7-[5-[[4-[4-[(Dimethylamino)sulfonyl]-1-piperazinyl]phenoxy]methyl]-1,3-dimethyl-1H-pyrazol-4-yl]-1-[2-(4-morpholinyl)ethyl]-3-[3-(1-naphthalenyloxy)propyl]-1H-indole-2-carboxylic acid, 98%, 5mg

5-(Phenylmethylidene)-1,3-diazinane-2,4,6-trione, 95.0%, 25g

2-(4-(2-(1-Isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoic acid, 98%, 50mg

5,7-Dibromo-3,4-dihydronaphthalen-1(2H)-one, 95.0%, 5g

2-Bromo-4-methoxythiophenol, 95%, 250mg

2-(2-(4-FLUOROBENZYL)PHENYL)ACETIC ACID, 95.0%, 2g

(4-(1,2,2-Triphenylvinyl)phenyl)methanamine, 97% mix TBC as stabilizer, 1g

Methyl 4-methoxy-2-nitrobenzoate, 95.0%, 10g

2-Bromo-5-pentafluoroethyl-thiophene, 1g

2-(3-Aminopyridin-4-yl)acetic acid, 95+%, 1g